AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25533593 — intervention group
Group type: COMPARATOR
Intervention: Usual rehabilitation
Number of subjects: 0
Study 23700131 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory stimuli presented from the same side as tactile stimuli
Number of subjects: 0
Study 23700131 — intervention group
Group type: COMPARATOR
Intervention: Auditory stimuli presented from the opposite side of tactile stimuli
Number of subjects: 0
Study 23700131 — intervention group
Group type: EXPERIMENTAL
Intervention: Sounds delivered from near the head
Number of subjects: 0
Study 23700131 — intervention group
Group type: EXPERIMENTAL
Intervention: Back of the hand stimulated
Number of subjects: 0
Study 23700131 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm of the hand stimulated
Number of subjects: 0
Study 16100228 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer training
Number of subjects: 76
Study 16100228 — intervention group
Group type: EXPERIMENTAL
Intervention: Group training
Number of subjects: 76
Study 16100228 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 76
Study 12548439 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-inflammatory diet (AID) with arachidonic acid intake of less than 90 mg/day
Number of subjects: 68
Study 12548439 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil capsules (30 mg/kg body weight)
Number of subjects: 68
Study 12548439 — intervention group
Group type: EXPERIMENTAL
Intervention: AID with fish oil
Number of subjects: 68
Study 12548439 — intervention group
Group type: COMPARATOR
Intervention: Normal western diet (WD)
Number of subjects: 68
Study 11097588 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye rubbing (15 times) without exposure to allergens
Number of subjects: 33
Study 11097588 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye rubbing (15 times) after exposure to cat dander
Number of subjects: 33
Study 11097588 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye rubbing (20 times with more force) after exposure to cat dander
Number of subjects: 33
Study 8857871 — intervention group
Group type: EXPERIMENTAL
Intervention: HMO enrollment for severely mentally ill subjects
Number of subjects: 250
Study 8857871 — intervention group
Group type: COMPARATOR
Intervention: HMO enrollment for controls without diabetes mellitus
Number of subjects: 250
Study 8857871 — intervention group
Group type: COMPARATOR
Intervention: HMO enrollment for patients with diabetes mellitus
Number of subjects: 250
Study 8857871 — intervention group
Group type: EXPERIMENTAL
Intervention: Community mental health service use among severely mentally ill subjects
Number of subjects: 250
Study 8857871 — intervention group
Group type: EXPERIMENTAL
Intervention: HMO costs of care per member per month for severely mentally ill subjects
Number of subjects: 250
Study 8857871 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of general medical care among severely mentally ill subjects
Number of subjects: 250
Study 1320416 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (Logiparin)
Number of subjects: 131
Study 1320416 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 6472365 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetohydroxamic acid (15 mg per kilogram of body weight per day, in divided oral doses)
Number of subjects: 37
Study 6472365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 6472365 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetohydroxamic acid
Number of subjects: 37
Study 31816018 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial urokinase
Number of subjects: 993
Study 31155667 — intervention group
Group type: EXPERIMENTAL
Intervention: SIPPC‐RE (Reinforcement Learning and Error‐Based Learning)
Number of subjects: 30
Study 31155667 — intervention group
Group type: COMPARATOR
Intervention: SIPPC‐R (Reinforcement Learning only)
Number of subjects: 30
Study 31155667 — intervention group
Group type: EXPERIMENTAL
Intervention: SIPPC‐TD (Typically Developing)
Number of subjects: 30
Study 27384376 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg every 8 hours)
Number of subjects: 113
Study 27384376 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen (1 g every 6 hours)
Number of subjects: 113
Study 27384376 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 113
Study 27384376 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 113
Study 27384376 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Ibuprofen and Acetaminophen
Number of subjects: 113
Study 25717250 — intervention group
Group type: EXPERIMENTAL
Intervention: LC+IOC treatment
Number of subjects: 371
Study 25717250 — intervention group
Group type: COMPARATOR
Intervention: Routine LC treatment
Number of subjects: 371
Study 23981814 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of inositol and alpha lipoic acid
Number of subjects: 155
Study 21254162 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 112
Study 21254162 — intervention group
Group type: EXPERIMENTAL
Intervention: Emtricitabine/TDF (FTC/TDF)
Number of subjects: 112
Study 21254162 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir (ETV)
Number of subjects: 112
Study 19065672 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil
Number of subjects: 0
Study 19065672 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine add‐on
Number of subjects: 0
Study 17708158 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold blood cardioplegia solution with Technetium (Tc-99m) tracer
Number of subjects: 20
Study 17708158 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold blood cardioplegia solution
Number of subjects: 20
Study 15113965 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supervised iron supplementation [3-6 mg/(kg.d)]
Number of subjects: 1049
Study 15113965 — intervention group
Group type: COMPARATOR
Intervention: Twice weekly supervised iron supplementation [6-12 mg/(kg.wk)]
Number of subjects: 1049
Study 15113965 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily unsupervised iron supplementation
Number of subjects: 1049
Study 15113965 — intervention group
Group type: COMPARATOR
Intervention: Twice weekly unsupervised iron supplementation
Number of subjects: 1049
Study 12040766 — intervention group
Group type: EXPERIMENTAL
Intervention: Hatha yogic exercises for 1 hour every morning, 6 days a week for six months
Number of subjects: 28
Study 12040766 — intervention group
Group type: EXPERIMENTAL
Intervention: Hatha yogic exercises
Number of subjects: 28
Study 12040766 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical exercise training (PT)
Number of subjects: 28
Study 9701417 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide (600 microg)
Number of subjects: 0
Study 9701417 — intervention group
Group type: COMPARATOR
Intervention: Orciprenaline sulphate (2.25 mg)
Number of subjects: 0
Study 7838917 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil (2 mg in saline)
Number of subjects: 30
Study 7838917 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl in water)
Number of subjects: 30
Study 3171331 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical prostaglandin E2 (0.02% solution)
Number of subjects: 0
Study 3171331 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 3171331 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical prostaglandin E2
Number of subjects: 0
Study 31063082 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up recommendations in radiology reports classified by a machine learning algorithm
Number of subjects: 318366
Study 31063082 — intervention group
Group type: EXPERIMENTAL
Intervention: Older patients
Number of subjects: 318366
Study 31063082 — intervention group
Group type: EXPERIMENTAL
Intervention: Male patients
Number of subjects: 318366
Study 31063082 — intervention group
Group type: EXPERIMENTAL
Intervention: CT studies
Number of subjects: 318366
Study 31063082 — intervention group
Group type: COMPARATOR
Intervention: Radiologist sex, presence of a trainee, years in practice
Number of subjects: 318366
Study 31063082 — intervention group
Group type: COMPARATOR
Intervention: Interradiologist variation
Number of subjects: 318366
Study 28437215 — intervention group
Group type: EXPERIMENTAL
Intervention: New contraceptive users (initiated ≤60 days before enrollment)
Number of subjects: 322
Study 28437215 — intervention group
Group type: COMPARATOR
Intervention: Established contraceptive users (initiated >60 days before enrollment)
Number of subjects: 322
Study 28437215 — intervention group
Group type: EXPERIMENTAL
Intervention: New DMPA users
Number of subjects: 322
Study 28437215 — intervention group
Group type: COMPARATOR
Intervention: Established DMPA users
Number of subjects: 322
Study 28437215 — intervention group
Group type: EXPERIMENTAL
Intervention: New COC users
Number of subjects: 322
Study 28437215 — intervention group
Group type: COMPARATOR
Intervention: Established COC users
Number of subjects: 322
Study 25569624 — intervention group
Group type: EXPERIMENTAL
Intervention: Skimmed milk (600 mL)
Number of subjects: 9
Study 25569624 — intervention group
Group type: COMPARATOR
Intervention: Orange drink (600 mL)
Number of subjects: 9
Study 24660603 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medication (established Chinese herbal formulas)
Number of subjects: 75
Study 24660603 — intervention group
Group type: COMPARATOR
Intervention: Western medication (leukotriene receptor antagonist and bronchial relaxant)
Number of subjects: 75
Study 21494635 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone exposure (250 ppb)
Number of subjects: 14
Study 21494635 — intervention group
Group type: COMPARATOR
Intervention: Clean air exposure
Number of subjects: 14
Study 18483475 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (CBT)
Number of subjects: 103
Study 18483475 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment with enhanced food monitoring accuracy (EFMA)
Number of subjects: 103
Study 18483475 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment with enhanced food monitoring accuracy (EFMA) plus reduced energy density eating (REDE)
Number of subjects: 103
Study 18483475 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced energy density eating (REDE)
Number of subjects: 103
Study 18483475 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 103
Study 16410033 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise ball
Number of subjects: 15
Study 16410033 — intervention group
Group type: COMPARATOR
Intervention: Wooden stool
Number of subjects: 15
Study 16410033 — intervention group
Group type: COMPARATOR
Intervention: Chair
Number of subjects: 15
Study 15213472 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill exercise group
Number of subjects: 32
Study 15213472 — intervention group
Group type: COMPARATOR
Intervention: Usual exercise group
Number of subjects: 32
Study 10858364 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanamivir (Relenza)
Number of subjects: 0
Study 9374583 — intervention group
Group type: EXPERIMENTAL
Intervention: vapocoolant spray + distraction
Number of subjects: 62
Study 9374583 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream + distraction
Number of subjects: 62
Study 9374583 — intervention group
Group type: COMPARATOR
Intervention: distraction alone (control)
Number of subjects: 62
Study 8247189 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone 60 mg/day
Number of subjects: 0
Study 8247189 — intervention group
Group type: COMPARATOR
Intervention: Retrobulbar radiotherapy (control)
Number of subjects: 0
Study 3033180 — intervention group
Group type: EXPERIMENTAL
Intervention: enalapril 20 mg daily
Number of subjects: 48
Study 3033180 — intervention group
Group type: COMPARATOR
Intervention: atenolol 50 mg daily
Number of subjects: 48
Study 3033180 — intervention group
Group type: EXPERIMENTAL
Intervention: enalapril (higher dose if diastolic BP > 90 mmHg)
Number of subjects: 48
Study 3033180 — intervention group
Group type: COMPARATOR
Intervention: atenolol (higher dose if diastolic BP > 90 mmHg)
Number of subjects: 48
Study 3033180 — intervention group
Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 48
Study 30551048 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS-Before
Number of subjects: 80
Study 30551048 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 80
Study 30551048 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS-During
Number of subjects: 80
Study 29923305 — intervention group
Group type: EXPERIMENTAL
Intervention: LI85008F (900 mg/d in two divided doses)
Number of subjects: 140
Study 29923305 — intervention group
Group type: EXPERIMENTAL
Intervention: LI85008F
Number of subjects: 140
Study 29923305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 26280946 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (ARG)
Number of subjects: 20
Study 26280946 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 20
Study 25380894 — intervention group
Group type: EXPERIMENTAL
Intervention: Myfenax
Number of subjects: 60
Study 25380894 — intervention group
Group type: COMPARATOR
Intervention: Other formulations of mycophenolate
Number of subjects: 60
Study 22200567 — intervention group
Group type: EXPERIMENTAL
Intervention: Disability Assessment Scale (hygiene domain)
Number of subjects: 279
Study 22200567 — intervention group
Group type: EXPERIMENTAL
Intervention: Disability Assessment Scale (dressing domain)
Number of subjects: 279
Study 22200567 — intervention group
Group type: EXPERIMENTAL
Intervention: Disability Assessment Scale (pain domain)
Number of subjects: 279
Study 22200567 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke-Adapted Sickness Impact Profile
Number of subjects: 279
Study 22200567 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke-Adapted Sickness Impact Profile (physical dimension)
Number of subjects: 279
Study 22200567 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver burden related to hygiene and dressing domain severity
Number of subjects: 279
Study 22200567 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver assistance requirement (hygiene domain)
Number of subjects: 279
Study 22200567 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver assistance requirement (dressing domain)
Number of subjects: 279
Study 19864311 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 173
Study 17852173 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioral therapy for complicated grief
Number of subjects: 51
Study 17852173 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 51
Study 16046981 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 L PEG‐E with a regular diet the day before colonoscopy followed by another 2 L PEG‐E on the day of the procedure (Group B)
Number of subjects: 141
Study 16046981 — intervention group
Group type: COMPARATOR
Intervention: 4 L PEG‐E with a liquid diet the day before colonoscopy (Group A)
Number of subjects: 141
Study 12104065 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 5
Study 12104065 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 5
Study 12104065 — intervention group
Group type: COMPARATOR
Intervention: Both statins
Number of subjects: 5
Study 10588465 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (daily intake: 216 mg eicosapentaenoic acid, 140 mg docosahexaenoic acid, 390 mg gamma‐linolenic acid, and 3480 mg linoleic acid)
Number of subjects: 26
Study 10588465 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 26
Study 10588465 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 8817707 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based psychiatric services
Number of subjects: 100
Study 8817707 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based psychiatric services
Number of subjects: 100
Study 1673616 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine 1.25 mg twice daily
Number of subjects: 20
Study 1673616 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine 2.5 mg twice daily
Number of subjects: 20
Study 1673616 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine combined with 1 mg/day bopindolol
Number of subjects: 20
Study 1673616 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 20
Study 7282610 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex carbohydrate diet (approximately 3000 kcal)
Number of subjects: 0
Study 7282610 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex carbohydrate diet
Number of subjects: 0
Study 7282610 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing amounts of carbohydrate (88 to 648 g carbohydrate/day)
Number of subjects: 0
Study 7282610 — intervention group
Group type: COMPARATOR
Intervention: Frequent feedings of a high carbohydrate diet
Number of subjects: 0
Study 31971089 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (4000 IU of Vit D3 daily for 4 weeks)
Number of subjects: 32
Study 29260292 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (4000 IU daily for 3 years)
Number of subjects: 158
Study 29260292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study 27796132 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser
Number of subjects: 20
Study 27796132 — intervention group
Group type: COMPARATOR
Intervention: Er:YAG laser
Number of subjects: 20
Study 26208981 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with bipolar disorder
Number of subjects: 30
Study 26208981 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study 23018287 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronome sound-guided group (MG)
Number of subjects: 67
Study 23018287 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 67
Study 23018287 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 67
Study 22090672 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Exercise (NG II) - brisk walking for 50 to 60 minutes, three to four days/week
Number of subjects: 98
Study 22090672 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt Intake Reduction (NG III) - to at least half of their previous intake
Number of subjects: 98
Study 22090672 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga (NG IV) - for 30 to 45 minutes/day, five days/week
Number of subjects: 98
Study 22090672 — intervention group
Group type: COMPARATOR
Intervention: Control Group (New Group I)
Number of subjects: 98
Study 18477130 — intervention group
Group type: EXPERIMENTAL
Intervention: PUVA
Number of subjects: 46
Study 18477130 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-PUVA
Number of subjects: 46
Study 18477130 — intervention group
Group type: EXPERIMENTAL
Intervention: NB-UVB
Number of subjects: 46
Study 16673797 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole cream (0.75% and 1%)
Number of subjects: 0
Study 16673797 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole gel (0.75% and 1%)
Number of subjects: 0
Study 16673797 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole lotion (0.75% and 1%)
Number of subjects: 0
Study 14700089 — intervention group
Group type: EXPERIMENTAL
Intervention: ABCD program
Number of subjects: 437
Study 14700089 — intervention group
Group type: COMPARATOR
Intervention: Regular benefits
Number of subjects: 437
Study 9785682 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermic cardiopulmonary bypass (35 degrees C‐37 degrees C)
Number of subjects: 90
Study 9785682 — intervention group
Group type: COMPARATOR
Intervention: Hypothermic cardiopulmonary bypass (28 degrees C)
Number of subjects: 90
Study 7631329 — intervention group
Group type: EXPERIMENTAL
Intervention: Active blood pressure treatment
Number of subjects: 190
Study 7631329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study 2115856 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 micrograms GHRH with water
Number of subjects: 16
Study 2115856 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 micrograms GHRH with water plus Tween 80
Number of subjects: 16
Study 2115856 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 micrograms intravenous GHRH
Number of subjects: 16
Study 2115856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 1276770 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthetic technique A
Number of subjects: 0
Study 1276770 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthetic technique B
Number of subjects: 0
Study 1276770 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 7308953 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam (Felden), applied once a day
Number of subjects: 0
Study 7308953 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin retard, applied twice daily (43% of cases) or sometimes (14%)
Number of subjects: 0
Study 29596010 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intensity whole body vibration (amplitude 8.82 mm, g force 2.76)
Number of subjects: 15
Study 29596010 — intervention group
Group type: COMPARATOR
Intervention: Low intensity whole body vibration (amplitude 4.53 mm, g force 2.21)
Number of subjects: 15
Study 29596010 — intervention group
Group type: COMPARATOR
Intervention: Other outcome measures
Number of subjects: 15
Study 30591069 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief medication review combined with a standardised communication strategy at hospital discharge
Number of subjects: 2100
Study 30591069 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 2100
Study 26880173 — intervention group
Group type: EXPERIMENTAL
Intervention: IV access present (Group 1: n = 27)
Number of subjects: 46
Study 26880173 — intervention group
Group type: COMPARATOR
Intervention: No IV access present (Group 2: n = 19)
Number of subjects: 46
Study 26880173 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular administration
Number of subjects: 46
Study 26880173 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration
Number of subjects: 46